“The nation faces an epidemic of drug and alcohol misuse. Every day, we hear news about related overdoses and accidental deaths as well as renewed city, state and federal attempts to stem the tide. So what should a friend or family member do if they think a loved one is in need of addiction treatment?”
PET scanning is giving Mass General Hospital researchers a whole new view of neurodegenerative diseases, which will hopefully make it easier to diagnose and treat patients for a variety of conditions, including ALS and Parkinson’s disease.
Patients with all classes of obesity, including, mild, moderate, and severe, with all stages of fibrosis, experienced gains in life years following laparoscopic Roux-en-Y gastric bypass, compared with standard management and intensive lifestyle changes, based on the model, Dr. Kathleen Corey reported at the annual meeting of the American Association for the Study of Liver Diseases.
Surgery also increased quality-adjusted life years (QALY) in those with moderate and severe obesity with all fibrosis stages, those with mild obesity and F2-F3 fibrosis, and in overweight patients with F3 fibrosis, said Dr Corey of Massachusetts General Hospital, Boston.
“Massachusetts General Hospital stands apart from its peers thanks to the access its doctors have to the cutting-edge discoveries pursued by its scientists. Mass General’s new Research Institute is designed to capitalize on that unique doctor-scientist partnership in ways that advance the practice of medicine.
‘At Mass General, the treatment you get tomorrow will be better than the treatment you get today because of our remarkable research enterprise,’ says Susan Slaugenhaupt, PhD, scientific director of the Research Institute, which will guide, support and promote all Mass General research.”
“As a patient and a doctor, Brewster yearned for a therapeutic arena in which patients could tell their full health stories and feel they were actually heard, not rushed out the door; and where doctors, as well, could share a little more with patients.”
A Massachusetts General Hospital research study suggests that a nanoparticle drug-delivery system that combines two complementary types of anticancer treatment could improve outcomes for patients with pancreatic cancer and other highly treatment-resistant tumors, while decreasing treatment toxicity. The new system, which combines a light-activated nanoparticle with a molecular therapy drug, reduced the dosage required to suppress tumor progression and metastatic outgrowth by 1,000 percent. Tayyaba Hasan, PhD, of the Wellman Center for Photomedicine is the corresponding author of the study.
Patients who are financially responsible for high out-of-pocket costs are significantly more likely to choose email and other online patient engagement methods over an expensive office visit to contact providers about their health concerns, according to a recent research study by a team that included Vicki Fung, PhD, from Mass General’s Mongan Institute for Health Policy. More than a third of patients who communicated with their providers by email said the activity reduced their phone contacts or in-person office visits, while a similar number said that keeping in email contact with providers helped to improve their health.
Researchers at Duke University Medical Center, Massachusetts General Hospital and Massachusetts Institute of Technology have developed a probe that can find, stick to and then light up residual cancer cells, making them easier for surgeons to see.